1-226986631-TGGG-TGGGG
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_020247.5(COQ8A):c.1844dupG(p.Ser616LeufsTer114) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,580 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_020247.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive ataxia due to ubiquinone deficiencyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- coenzyme Q10 deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020247.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COQ8A | NM_020247.5 | MANE Select | c.1844dupG | p.Ser616LeufsTer114 | frameshift | Exon 15 of 15 | NP_064632.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COQ8A | ENST00000366777.4 | TSL:1 MANE Select | c.1844dupG | p.Ser616LeufsTer114 | frameshift | Exon 15 of 15 | ENSP00000355739.3 | ||
| COQ8A | ENST00000366778.5 | TSL:1 | c.1688dupG | p.Ser564LeufsTer114 | frameshift | Exon 15 of 15 | ENSP00000355740.1 | ||
| ENSG00000288674 | ENST00000366779.6 | TSL:2 | n.*6571dupG | non_coding_transcript_exon | Exon 32 of 32 | ENSP00000355741.2 |
Frequencies
GnomAD3 genomes AF: 0.0000528 AC: 8AN: 151608Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000716 AC: 18AN: 251434 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461850Hom.: 0 Cov.: 33 AF XY: 0.0000206 AC XY: 15AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151730Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74094 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
The c.1844dupG variant in the ADCK3 gene causes a frameshift starting with codon Serine 616, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 114 of the new reading frame, denoted p.Ser616LeufsX114. This mutation is predicted to cause loss of normal protein function by resulting in the replacement of the last 32 amino acids of the ADCK3 protein by 113 incorrect amino acids, which is predicted to affect the secondary structure and function of the ADCK3 protein. Although this variant has not been previously reported to our knowledge, it is expected to be a pathogenic variant.
This sequence change creates a premature translational stop signal (p.Ser616Leufs*114) in the COQ8A gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 32 amino acid(s) of the COQ8A protein. This variant is present in population databases (rs761498232, gnomAD 0.03%). This premature translational stop signal has been observed in individuals with clinical features of coenzyme Q10 deficiency (PMID: 24218524, 32743982, 32961396, 34663476). ClinVar contains an entry for this variant (Variation ID: 214046). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects COQ8A function (PMID: 24218524). This variant disrupts a region of the COQ8A protein in which other variant(s) (p.Arg626His) have been observed in individuals with COQ8A-related conditions (internal data). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Autosomal recessive ataxia due to ubiquinone deficiency Pathogenic:1Other:1
Variant summary: CABC1 c.1844dupG (p.Ser616LeufsX114), located within the last exon, causes a frameshift which disrupts the last 32 amino acids of the encoded protein sequence and results in an extension of the protein, but is not predicted to undergo nonsense mediated decay. The variant allele was found at a frequency of 6.7e-05 in 282792 control chromosomes (gnomAD). c.1844dupG has been reported in the literature as a biallelic genotype in multiple individuals affected with Autosomal Recessive Ataxia Due To Ubiquinone Deficiency, including reports where symptoms have improved following CoQ10 supplementation, and has been found to segregate with the disease phenotype in at least one family (e.g. Liu_2014, Jiao_2020, Zhang_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32961396, 24218524, 32743982). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Three submitters classified the variant as pathogenic, and one classified it as uncertain significance. Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at